DocCheck AG

XETRA AJ91.DE

DocCheck AG Return on Equity (ROE) for the year ending December 31, 2023: 6.08%

DocCheck AG Return on Equity (ROE) is 6.08% for the year ending December 31, 2023, a -62.69% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

DocCheck AG Return on Equity (ROE) for the year ending December 31, 2022 was 16.31%, a -46.64% change year over year.
DocCheck AG Return on Equity (ROE) for the year ending December 31, 2021 was 30.56%, a 2.67% change year over year.
DocCheck AG Return on Equity (ROE) for the year ending December 31, 2020 was 29.77%, a 108.76% change year over year.
DocCheck AG Return on Equity (ROE) for the year ending December 31, 2019 was 14.26%, a 30.57% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

XETRA: AJ91.DE

DocCheck AG

CEO	Dr. Frank Nicolas Antwerpes
IPO Date	Jan. 30, 2012
Location	Germany
Headquarters	Vogelsanger Str. 66
Employees	433
Sector	Healthcare
Industries Telehealth Advertising & Marketing Digital Advertising Drugstores & Retail Pharmacies E-commerce Hospitals & Clinics Internet Services & Media Retail & Wholesale

Description

DocCheck AG offers marketing, customer relationship management, and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, and online and e-commerce services for healthcare market players. It also develops and implements communication strategies for new and traditional media on healthcare and business-to-business sectors; and promotes healthcare startups through seed funding. DocCheck AG is based in Cologne, Germany.

Key trends

Past 5 years